SCHEMBL27911749

SCHEMBL27911749

COc1ccc2c(c1OC)C(=C=O)OC2C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.49
▸ HPGD P15428 4/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 8/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ MAPT P10636 5/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ ALPL P05186 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ PLAA Q9Y263 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ HTT P42858 2/20 0.37
▸ HSD17B10 Q99714 5/20 0.36
▸ CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22703276 0.83 KDM4E (0.65) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7825295 0.83 KDM4E (0.65) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL11108478 0.69 NR3C1 (0.53) KDM4EHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL27784542 0.69 KDM4E (0.57) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL11109388 0.66 KDM4E (0.44) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL11215947 0.66 ACHE (0.45) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7830543 0.66 KDM4E (1.00) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL11107057 0.64 NR3C1 (0.65) KDM4EHPGDALDH1A1LMNAHSD17B10
SCHEMBL559163 0.64 PARP1 (0.47) KDM4EHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL28851736 0.64 KDM4E (0.50) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214493-B The selective reduction of chirality B catalyst is utilized to prepare (-) α-Noscapine NANJING ACESYS PHARMATECH CO., LTD. (CN) 2015-12-23 — — CN disclosed
CN-103214493-A Method for generating narcotine by selective reduction utilizing chiral boron catalyst NANJING ACESYS PHARMATECH CO LTD 2013-07-24 — — CN disclosed
Send feedback